BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 11:31:00 AM | Browse: 363 | Download: 379
Publication Name World Journal of Gastroenterology
Manuscript ID 5866
Country/Territory Japan
2013-09-28 17:19
Peer-Review Started
2013-09-29 14:27
To Make the First Decision
2013-12-03 19:11
Return for Revision
2013-12-16 15:53
2013-12-24 15:32
Second Decision
2014-02-20 15:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-02-20 16:03
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-04-11 10:17
Publish the Manuscript Online
2014-04-17 13:27
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer
Manuscript Source Invited Manuscript
All Author List Atsuya Takeda, Naoko Sanuki and Etsuo Kunieda
Funding Agency and Grant Number
Corresponding author Atsuya Takeda, MD, PhD, Radiation Oncology Center, Ofuna Chuo Hospital, 6-2-24, Ofuna, Kamakura, Kanagawa 247-0056, Japan. takeda@1994.jukuin.keio.ac.jp
Keywords Oligometastasis; Colorectal cancer; Radiation therapy; Stereotactic ablation body radiation therapy; Local therapy
Core Tip Systemic chemotherapy has enabled prolongation of survival in patients with stage Ⅳ colorectal cancer. This has subsequently increased the relative significance of local therapy. Resection is the standard therapy in most settings. Recently, stereotactic body radiotherapy (SBRT) provides high local control with minimal morbidity, both in the curative and palliative setting. The indications of SBRT include liver, lung, isolated lymph nodes, spinal and adrenal metastasis, and post-surgical pelvic recurrence. However, few reports with a high level of evidence have indicated the efficacy of SBRT. Hereafter, the optimal indication of SBRT needs to be prospectively investigated to obtain convincing evidence.
Publish Date 2014-04-17 13:27
Citation Takeda A, Sanuki N, Kunieda E. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer. World J Gastroenterol 2014; 20(15): 4220-4229
Url http://www.wjgnet.com/1007-9327/full/v20/i15/4220.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i15.4220
Full Article (PDF) WJG-20-4220.pdf
Full Article (Word) WJG-20-4220.doc
Manuscript File 5866-Review.docx
Answering Reviewers 5866-Answering reviewers.pdf
Copyright License Agreement 5866-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5866-Language certificate.pdf
Peer-review Report 5866-Peer reviews.pdf
Scientific Editor Work List 5866-Scientific editor work list.doc